As per PitchBook’s Q2 2021 European Venture Report, capital raised by European VC reserves is poised to exceed 2020 figures continuously conclusion. Restricted accomplices and general accomplices have been sure about their capacity to discover quality speculation openings among a wide scope of new companies across areas all through the landmass, says PitchBook Senior Analyst, EMEA Private Capital Nalin Patel.
In this blog entry, we’re looking all the more closely at high-performing VC Netherlands in the Netherlands. Specifically, we are featuring the top VC assets the nation over by IRR, or Internal Rate of Return, as of September 9, 2021.
Note that clicking on any asset or organization name in the rundown beneath will take you to a PitchBook profile review. Our profile sneak peaks give a superficial feeling of the sorts of powerful information PitchBook customers can access with their membership.
Top 7 Dutch VC assets by IRR
BioGeneration Ventures II
IRR: 104%
Vintage: 2012
Fund size: €15M
Close date: December 2012
Situated in Naarden, Netherlands and led by Founder and Managing Partner Edward van Wezel, BioGeneration Ventures II is a funding reserve that makes interests into medical care organizations across seed, early-and late-stages. The completely contributed reserve has submitted funding to Maastricht’s Cristal Therapeutics and Oss-based Synaffix, both medication disclosure new businesses, among different organizations.
Acrobator Angel Fund
IRR: 88%
Vintage: 2011
Asset size: €2.4M
Close date: January 2019
Amsterdam-based VC firm Acrobator Ventures runs the Acrobator Angel Fund, which will in general make seed-and beginning phase interests in data innovation new businesses. The asset group comprises of Co-originator and General Partner Bas Godska and Co-organizer and Managing Partner Joachim Laqueur. Late ventures have included Berlin-based monetary programming Monite, Singaporean time-following application Clockster, and the Bay Area’s shared AI stage Omdena.
FORBION Capital Fund IV
IRR: 71.28%
Vintage: 2018
Asset size: €360M
Close date: September 2018
Headquartered in Naarden, FORBION is a VC firm that works closely with business visionaries to construct life sciences organizations with innovations and items intended to change people groups’ lives. FORBION IV spotlights on medical care open doors in the EU and UK, just as in North America. The asset has eight dynamic speculations, including the Naarden-based medication disclosure startup Azafaros, German biopharmaceutical organization Catalym and Montreal’s medication engineer Inversago, among others.
FORBION Capital Fund III
IRR: 44.04%
Vintage: 2015
Asset size: €183M
Close date: April 2016
A member from the FORBION store family, FORBION III gives money to beginning phase VC medical care new businesses, and especially in drug-, gadget and diagnostics organizations. Around 70% of the asset will be focused on Europe, with the rest of to be distributed across the United States and Canada. A couple of FORBION III’s dynamic speculations incorporate Brighton, UK-based Enterprise Therapeutics, Nijmegen’s Escalier Biosciences and Amsterdam’s NorthSea Therapeutics.
Newion Investments II
IRR: 33%
Vintage: 2011
Asset size: €48M
Close date: April 2011
Amsterdam’s Newion Investments II is an investment store whose reserve strategy incorporates putting principally in right on time and later-stage data innovation new companies. Of the asset’s eight dynamic ventures, the latest incorporate social publicizing stage The Next Ad and representative administration programming L1NDA—both situated in Amsterdam. The Luxembourg-based European Investment Fund, an asset of assets, is a restricted accomplice on Newion Investments II.
FCF I Co-Invest Fund I
IRR: 30.77%
Vintage: 2009
Asset size: €54M
Close date: September 2010
One more asset oversaw by FORBION, FCF I Co-Invest Fund I is a completely contributed co-speculation general asset drove by Operating Partner Sander van Deventer. Notwithstanding FORBION, Oslo, Norway-based insurance agency Kommunal Landspensjonskasse is a restricted accomplice on FCF I, which circulated capital uniformly across right on time and later-stage VC medical care organizations. The asset has two previous speculations—Suffolk, UK-based medication disclosure organization Xention and Rhein Biotech, a biotech organization settled in Düsseldorf, Germany.
henQ II
IRR: 30.30%
Vintage: 2009
Asset size: €9M
Close date: October 2009
henQ II is a early phase VC store managed by HenQ, an investment firm settled in Amsterdam. The asset looks to put resources into youthful innovation organizations that offer an adaptable item and that are overseen by solid groups. The asset, which targets worldwide development markets like new media, portable and programming, has seven previous ventures, including the Netherlands’ SEOshop Group and CWR Mobility.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No The Money Fly journalist was involved in the writing and production of this article.
